Member Info for Dibs61

Thanks Reprobus. :)

Yes decent buying today. Seems to have a floor around 1.8/1.9

This looks to be one of the cheapest gold stocks on the market @ £5m MC when you look at their targets/prospects. I can see this being a lot higher after another year of drilling here.

MM’s bidding this up because they simply don’t have enough stock! I can dummy sell in quantity for 43.25 above quoted bid.

Heaven only knows what this will do when JV drops.

greendave- your £2.00 forecast for 2022 is quite conservative IMO. That would value the company @ a mere £64m. Given they already have 500k ozs resources OR 1m ozs on updated cut off grades I anticipate they will be upgraded to 2 perhaps 3m ozs by then with AAZ beavering away.

There will be a mad scramble for shares here!

It’s really a perfect storm if you factor in the gold bull market.

If you are a long term investor then this looks like a very attractive investment. Strong backing. Sound plan. Project reasonably advanced already. Shallow HIGH grade deposits and only literally scratched the surface.

And perhaps most importantly many commentators suggest we are entering a Resources bull market.

Looking forward to next week and will hold and see what happens. In any case may not have any choice until stock is added to my account.

Tradegate 0.93 euros up 11% = 0.84p

scotlouie, NICGM and enteleon many thanks for your very helpful responses.

It’s clear then that AN is in it for the long game. How exciting. What a journey it will be (and with respect to all, has been already!)

It may seem a moot point to some but when I read about this being taken over by a ‘Pharma’ ie.drug company I have to correct. This is a diagnostic device company and so the likely suitors will be a Roche or an Abbot, an Illumina or a Thermo Fisher.... just saying.

A question for the LTH’s. Do we know what AN’s longer term strategy is for the company post FDA? Is he looking for an exit and sale? He still has a sizeable holding. And he seems a young energetic enthusiastic kind of chap.

Managed my top up just before the bell -250,630 @ 1.9

Ready for the results now.

This SP drop seems very odd in the circumstances. Logic would suggest that in the current perilous situation treatments would be top priority. All this government seem to be interested in is the headline grabbing ‘jabs in arms’ hoping to stop people getting Covid.

Meanwhile there are tens of thousands who need treatment! And hundreds of them are dying, possibly needlessly every day because clearly the treatments we have are not enough!

Meanwhile the obsession with vaccines (of which there is clearly no where near enough supply) continues.

Absolutely bonkers and that is reflected perfectly in the SP here. We should be rocketing up.

fairview - those that are well researched here know the answer to that question.

The market often throws up opportunities like this that investors misinterpret.

Kicking my heels a bit because I want to top up at these low levels but no liquidity atm!

Nice post scotlouie - one of the trusted long term posters here. Thx

I think changing name to Parsortix is a great idea. Only caveat is if company is planning on building out product range? In that case I suppose at some point non-core could be spun off.

And can you imagine what this would be valued as on NASDAQ?!

e_v_a the new incarnation of ‘Eva’ has joined whylie in the greenbin. I can’t be bothered by the plethora of their self obsessed attention seeking crap clogging up the board.

whylie - in view of the fact that you rarely if ever post anything constructive on this board you are now consigned to the green bin. Not that you will care but my life will be slightly richer for it. Continually antagonistic, deliberately provocative, and adopting a superior ‘I’m better than all of you’ yet clearly insecure attention seeking nature you are just not worth it.

Last tree shake now before trial news?

The point is that up until the 1st January this new pathway could not be implemented and was therefore not available because we were still subject to EU rules.

It seems reasonable to assume that conversations will have taken place between SNG and the UK regulatory authorities to establish the faster route to market ie.the existing route or the ILAP route, if indeed there is an option.

Someone lost their patience this morning! Can’t be long to wait now, CM said ‘early’ new year for results though we all know these AIM CEO’s have a different interpretation of these words than we do!

I’m bumping this thread because with everyone wanting to know why the trial hasn’t started this ‘could’ be at least part of the reason why.

The new post Brexit ILAP route to early access for promising treatments that was launched on 1.1.2021. This looks significant to me.

See my earlier post in this thread.

Well yesterday afternoons rally soon faded out. Jupiter still selling? They are under no obligation to advise when they have gone to zero. So the only way we will know is if we see a sustained SP rise. To be fair we have come up from below 40 to this level already but clearly someone’s still offloading. If you want to enter or add it’s a good opportunity though. I’m looking to add substantially before the end of the month ideally.

SP target pre-FDA £1 minimum

Shan yes good point